Candidate genetic variants and antidepressant-related fall risk in middle-aged and older adults
Open Access
- 14 April 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (4) , e0266590
Abstract
Background: Antidepressant use has been associated with increased fall risk. Antidepressant-related adverse drug reactions (e.g. orthostatic hypotension) depend partly on genetic variation. We hypothesized that candidate genetic polymorphisms are associated with fall risk in older antidepressant users. Methods: The association between antidepressant use and falls was cross-sectionally investigated in a cohort of Dutch older adults by logistic regression analyses. In case of significant interaction product term of antidepressant use and candidate polymorphism, the association between the variant genotype and fall risk was assessed within antidepressant users and the association between antidepressant use and fall risk was investigated stratified per genotype. Secondly, a look-up of the candidate genes was performed in an existing genome-wide association study on drug-related falls in antidepressant users within the UK Biobank. In antidepressant users, genetic associations for our candidate polymorphisms for fall history were investigated. Results: In antidepressant users(n = 566), for rs28371725 (CYP2D6*41) fall risk was decreased in TC/variant allele carriers compared to CC/non-variant allele carriers (OR = 0.45, 95% CI 0.26–0.80). Concerning rs1057910 (CYP2C9*3), fall risk was increased in CA/variant allele carriers compared to AA/non-variant allele carriers (OR = 1.95, 95% CI 1.17–3.27). Regarding, rs1045642 (ABCB1), fall risk was increased in AG/variant allele carriers compared to GG/non-variant allele carriers (OR = 1.69, 95% CI 1.07–2.69). Concerning the ABCB1-haplotype (rs1045642/rs1128503), fall risk was increased in AA-AA/variant allele carriers compared to GG-GG/non-variant allele carriers (OR = 1.86, 95% CI 1.05–3.29). In the UK Biobank, in antidepressant users(n = 34,000) T/variant-allele of rs28371725 (CYP2D*41) was associated with increased fall risk (OR = 1.06, 95% CI 1.01–1.12). G/non-variant-allele of rs4244285 (CY2C19*2) was associated with decreased risk (OR = 0.96, 95% CI 0.92–1.00). Conclusion: This is the first study showing that certain genetic variants modify antidepressant-related fall risk. The results were not always consistent across the studies and should be validated in a study with a prospective design. However, pharmacogenetics might have value in antidepressant (de)prescribing in falls prevention.Keywords
Funding Information
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Clementine Brigitta Maria Dalderup fund (20713 and 7303)
- ZonMw (6130.0031)
- Nederlandse Zuivel Organisatie
- Netherlands Consortium Healthy Ageing
- Ministerie van Volksgezondheid, Welzijn en Sport
- the Research Institute for Diseases in the Elderl
- the Netherlands Genomics Initiative
- Welcome Trust medical charity, Medical Research Council, Department of Health, Scottish Government and the Northwest Regional Development Agency
- Welsh Government, British Heart Foundation, Cancer Research UK and Diabetes UK
- National Institute for Health Research
This publication has 51 references indexed in Scilit:
- Applications of CYP450 Testing in the Clinical SettingMolecular Diagnosis & Therapy, 2013
- Dose–response relationship between selective serotonin re‐uptake inhibitors and injurious falls: a study in nursing home residents with dementiaBritish Journal of Clinical Pharmacology, 2012
- Rationale and design of the B-PROOF study, a randomized controlled trial on the effect of supplemental intake of vitamin B12and folic acid on fracture incidenceBMC Geriatrics, 2011
- Societal Consequences of Falls in the Older Population: Injuries, Healthcare Costs, and Long-Term Reduced Quality of LifeJournal of Trauma: Injury, Infection & Critical Care, 2011
- Very important pharmacogene summaryPharmacogenetics and Genomics, 2011
- Cohort Profile: The Longitudinal Aging Study AmsterdamInternational Journal of Epidemiology, 2011
- ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depressionPharmacogenetics and Genomics, 2010
- Polymorphism of human cytochrome P450 enzymes and its clinical impactDrug Metabolism Reviews, 2009
- PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage AnalysesThe American Journal of Human Genetics, 2007
- A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depressionThe Pharmacogenomics Journal, 2002